Vesalio Appoints Daniel Davis to Its Board of Directors and as Advisor to the CEO
Daniel Davis is appointed to Vesalio’s Board of Directors and as Advisor to the CEO
Daniel Davis is appointed to Vesalio’s Board of Directors and as Advisor to the CEO
Results showed a reduction in infarct size compared with conventional PCI in STEMI patients with large thrombus burden. Results were presented as Late-Breaking Science at ESC Congress 2026.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval
NATURE trial, a prospective randomized controlled trial comparing the safety and effectiveness of thrombectomy using enVast before conventional PCI versus standard of care alone, was selected for the prestigious Late-Breaking Clinical Trials session at the European Society of Cardiology Congress.
Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform.
Company advances global neuro-intervention footprint with new CE-marked devices for vasospasm and stroke, and expanded U.S. indications for aspiration catheters.
Procedure cards to support physicians during procedures. Contact Vesalio Marketing for printing.
Procedure cards to support physicians during procedures. Contact Vesalio Marketing for printing.
pVasc Compatible Catheters Cook Sheaths w/ Removable Valves
Neva and NeVa NET cases in a simple pdf format. Note that some of these cases are available in detail on NeVa Clinical Cases Page on the website.
Contact Market Development for the PowerPoint version and for help in organizing a NeVa Induction Webinar if needed.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
by removing vascular occlusions and restoring blood flow
Please select your region to enter our world of innovation:
"*" indicates required fields